Category Archives: HIV/AIDS

Could GeneXpert viral load test represent a potential win-win for the TB and HIV responses?

By on .

Researchers comparing measures in India study say yes The breakthrough represented by the development and WHO approval in 2010 of the GeneXpert rapid test to detect tuberculosis and TB drug resistantance still stands alone among innovative diagnostic advances against the disease, researchers from McGill University writing to The Lancet Global Health journal have noted. But […]

Test and start policy doubles numbers initiating treatment at PEPFAR Lesotho sites

By on .

MMWR reports preliminary results of Lesotho’s adoption of WHO universal treatment guidelines The first country in sub-Saharan Africa to adopt World Health Organization guidelines recommending all people with HIV have immediate access to the antiretroviral medicine that prevents illness and transmission saw the average number of patients starting treatment of the virus increase by nearly […]

Trump plan would limit PEPFAR “epidemic control” efforts to 12 countries

By on .

Remember the days when the antiretroviral medicine that saved the lives of people living with HIV — and that would later be proven to prevent transmission of the virus — was provided to the people who needed it only in countries that could afford it? That past, when lines between life and death followed the […]

We’re reading lessons of PEPFAR, and from progress gained and abandoned

By on .

PEPFAR: Oh what good you have done!  From South Africa’s first reported AIDS patient in 1982, to the years when the epidemic filled hospitals and graveyards, to the miraculous but selective deliverance of antiretroviral medicine, to the President’s Emergency Plan for AIDS Relief, to a White House budget proposal for 2018 that threatens to reverse […]

Advanced illness at HIV treatment start is dropping in some countries surveyed, still seen in a third of new patients

By on .

The prevalence of advanced HIV among people beginning antiretroviral treatment has declined in eight of 10 resource-constrained countries surveyed, while median immune cell counts went up — indicating less weakened immune systems — in six countries, indicating improved access to testing and treatment, but still, about one third of patients starting treatment during the time […]

Tracking patients raises numbers returning to antiretroviral treatment — but tracking the right patients would be better still

By on .

When community health workers went looking for patients who had started antiretroviral treatment but had stopped showing up for care at 14 clinics across Uganda, Kenya and Tanzania, 13 percent of those sought returned to treatment. That represented a significant, if still small improvement over the 10 percent who returned for care when no effort […]

Office of AIDS Research gets a shout out — and a $544 million cut in NIH budget “justification”

By on .

Citing priorities of HIV research slated to lose hundreds of millions of dollars, dispatching the Fogarty International Center while extolling its contributions, document released by National Institutes of Health director tallies steep and devastating cuts without explanation ” . . .the HIV epidemic represents the most serious health crisis of our time, a critical and […]

Stockouts among obstacles to TB/HIV treatment monitoring, training evaluation finds

By on .

Training may have supported care outcome improvements In South Africa, where in 2014 an estimated 6,8 million people were living with HIV, and where an estimated 450,000 people became sick with tuberculosis that year, healthcare providers equipped to meet their needs are stretched thin, and training to help nurses manage patients who are infected with […]

Community-based and comprehensive, response to HIV among people injecting drugs in Athens reversed climb in new cases

By on .

Before 2011, when HIV infections among people who injected drugs in Athens, Greece rose suddenly and steeply, the epidemic of the virus in that country was classified as a low-level one; affecting less than 1 percent of the general population, and less than 5 percent of any of the populations at greatest risk. In the […]